vs
Side-by-side financial comparison of Context Therapeutics Inc. (CNTX) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
Context Therapeutics Inc. is the larger business by last-quarter revenue ($1.2M vs $881.5K, roughly 1.4× Serve Robotics Inc.). Context Therapeutics Inc. runs the higher net margin — -1403.9% vs -3888.1%, a 2484.2% gap on every dollar of revenue. On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs 328.2%). Context Therapeutics Inc. produced more free cash flow last quarter ($-1.9M vs $-46.1M). Over the past eight quarters, Context Therapeutics Inc.'s revenue compounded faster (154.3% CAGR vs -3.5%).
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative targeted therapies for hormone-driven cancers. Its core pipeline includes candidates for breast, ovarian and other gynecologic malignancies, primarily serving oncology patient populations across North America and Europe.
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
CNTX vs SERV — Head-to-Head
Income Statement — Q3 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $881.5K |
| Net Profit | $-17.5M | $-34.3M |
| Gross Margin | — | -757.3% |
| Operating Margin | -1503.7% | -4572.1% |
| Net Margin | -1403.9% | -3888.1% |
| Revenue YoY | 328.2% | 400.1% |
| Net Profit YoY | -197.2% | -161.3% |
| EPS (diluted) | $-0.22 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $881.5K | ||
| Q3 25 | — | $687.0K | ||
| Q2 25 | — | $642.0K | ||
| Q1 25 | — | $440.5K | ||
| Q4 24 | — | $176.3K | ||
| Q3 24 | $1.2M | $222.0K | ||
| Q2 24 | $840.1K | $468.0K | ||
| Q1 24 | — | $946.7K |
| Q4 25 | — | $-34.3M | ||
| Q3 25 | — | $-33.0M | ||
| Q2 25 | — | $-20.9M | ||
| Q1 25 | — | $-13.2M | ||
| Q4 24 | — | $-13.1M | ||
| Q3 24 | $-17.5M | $-8.0M | ||
| Q2 24 | $-2.3M | $-9.0M | ||
| Q1 24 | — | $-9.0M |
| Q4 25 | — | -757.3% | ||
| Q3 25 | — | -637.4% | ||
| Q2 25 | — | -445.3% | ||
| Q1 25 | — | -333.4% | ||
| Q4 24 | — | -371.7% | ||
| Q3 24 | — | -70.3% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 62.8% |
| Q4 25 | — | -4572.1% | ||
| Q3 25 | — | -5067.8% | ||
| Q2 25 | — | -3527.1% | ||
| Q1 25 | — | -3406.6% | ||
| Q4 24 | — | -7701.3% | ||
| Q3 24 | -1503.7% | -3804.1% | ||
| Q2 24 | -367.6% | -1828.2% | ||
| Q1 24 | — | -814.6% |
| Q4 25 | — | -3888.1% | ||
| Q3 25 | — | -4806.4% | ||
| Q2 25 | — | -3247.7% | ||
| Q1 25 | — | -3000.5% | ||
| Q4 24 | — | -7441.8% | ||
| Q3 24 | -1403.9% | -3601.8% | ||
| Q2 24 | -268.3% | -1931.2% | ||
| Q1 24 | — | -954.7% |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-0.22 | $-0.20 | ||
| Q2 24 | $-0.04 | $-0.27 | ||
| Q1 24 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.8M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.9M | $350.7M |
| Total Assets | $86.3M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $106.2M | ||
| Q3 25 | — | $116.8M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $197.8M | ||
| Q4 24 | — | $123.3M | ||
| Q3 24 | $84.8M | $50.9M | ||
| Q2 24 | $101.5M | $28.8M | ||
| Q1 24 | — | — |
| Q4 25 | — | $350.7M | ||
| Q3 25 | — | $283.9M | ||
| Q2 25 | — | $207.2M | ||
| Q1 25 | — | $210.2M | ||
| Q4 24 | — | $131.7M | ||
| Q3 24 | $83.9M | $56.2M | ||
| Q2 24 | $101.1M | $28.5M | ||
| Q1 24 | — | $-8.8M |
| Q4 25 | — | $367.8M | ||
| Q3 25 | — | $299.1M | ||
| Q2 25 | — | $214.3M | ||
| Q1 25 | — | $216.6M | ||
| Q4 24 | — | $139.6M | ||
| Q3 24 | $86.3M | $61.5M | ||
| Q2 24 | $102.7M | $32.8M | ||
| Q1 24 | — | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.9M | $-29.6M |
| Free Cash FlowOCF − Capex | $-1.9M | $-46.1M |
| FCF MarginFCF / Revenue | -156.0% | -5234.4% |
| Capex IntensityCapex / Revenue | 0.6% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-29.6M | ||
| Q3 25 | — | $-25.2M | ||
| Q2 25 | — | $-16.0M | ||
| Q1 25 | — | $-9.5M | ||
| Q4 24 | — | $-6.3M | ||
| Q3 24 | $-1.9M | $-5.5M | ||
| Q2 24 | $-3.4M | $-5.7M | ||
| Q1 24 | — | $-4.1M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-36.5M | ||
| Q2 25 | — | $-22.0M | ||
| Q1 25 | — | $-12.9M | ||
| Q4 24 | — | $-11.1M | ||
| Q3 24 | $-1.9M | $-10.1M | ||
| Q2 24 | — | $-6.5M | ||
| Q1 24 | — | $-4.1M |
| Q4 25 | — | -5234.4% | ||
| Q3 25 | — | -5314.1% | ||
| Q2 25 | — | -3426.8% | ||
| Q1 25 | — | -2934.1% | ||
| Q4 24 | — | -6307.8% | ||
| Q3 24 | -156.0% | -4529.7% | ||
| Q2 24 | — | -1396.6% | ||
| Q1 24 | — | -431.1% |
| Q4 25 | — | 1872.1% | ||
| Q3 25 | — | 1649.6% | ||
| Q2 25 | — | 940.4% | ||
| Q1 25 | — | 785.7% | ||
| Q4 24 | — | 2755.1% | ||
| Q3 24 | 0.6% | 2070.7% | ||
| Q2 24 | 0.0% | 169.8% | ||
| Q1 24 | — | 0.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
